chr16-83915051-G-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_012213.3(MLYCD):​c.1044G>T​(p.Glu348Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00149 in 1,614,250 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 5 hom. )

Consequence

MLYCD
NM_012213.3 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4O:1

Conservation

PhyloP100: -1.43
Variant links:
Genes affected
MLYCD (HGNC:7150): (malonyl-CoA decarboxylase) The product of this gene catalyzes the breakdown of malonyl-CoA to acetyl-CoA and carbon dioxide. Malonyl-CoA is an intermediate in fatty acid biosynthesis, and also inhibits the transport of fatty acyl CoAs into mitochondria. Consequently, the encoded protein acts to increase the rate of fatty acid oxidation. It is found in mitochondria, peroxisomes, and the cytoplasm. Mutations in this gene result in malonyl-CoA decarboyxlase deficiency. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052485764).
BP6
Variant 16-83915051-G-T is Benign according to our data. Variant chr16-83915051-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 320731.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, not_provided=1, Uncertain_significance=1}. Variant chr16-83915051-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00111 (169/152358) while in subpopulation NFE AF= 0.0021 (143/68038). AF 95% confidence interval is 0.00182. There are 0 homozygotes in gnomad4. There are 74 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MLYCDNM_012213.3 linkuse as main transcriptc.1044G>T p.Glu348Asp missense_variant 5/5 ENST00000262430.6 NP_036345.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MLYCDENST00000262430.6 linkuse as main transcriptc.1044G>T p.Glu348Asp missense_variant 5/51 NM_012213.3 ENSP00000262430 P1O95822-1

Frequencies

GnomAD3 genomes
AF:
0.00111
AC:
169
AN:
152240
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000470
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00210
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00119
AC:
296
AN:
249582
Hom.:
1
AF XY:
0.00112
AC XY:
152
AN XY:
135406
show subpopulations
Gnomad AFR exome
AF:
0.000452
Gnomad AMR exome
AF:
0.0000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.00224
Gnomad OTH exome
AF:
0.00165
GnomAD4 exome
AF:
0.00153
AC:
2234
AN:
1461892
Hom.:
5
Cov.:
30
AF XY:
0.00143
AC XY:
1042
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00129
Gnomad4 NFE exome
AF:
0.00187
Gnomad4 OTH exome
AF:
0.00108
GnomAD4 genome
AF:
0.00111
AC:
169
AN:
152358
Hom.:
0
Cov.:
33
AF XY:
0.000993
AC XY:
74
AN XY:
74510
show subpopulations
Gnomad4 AFR
AF:
0.000361
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000470
Gnomad4 NFE
AF:
0.00210
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00148
Hom.:
0
Bravo
AF:
0.00116
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000780
AC:
3
ESP6500EA
AF:
0.00169
AC:
14
ExAC
AF:
0.00161
AC:
194
EpiCase
AF:
0.00125
EpiControl
AF:
0.00190

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Deficiency of malonyl-CoA decarboxylase Benign:2Other:1
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpreted as Uncertain significance and reported on 05-24-2018 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 05, 2020In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2016- -
MLYCD-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 05, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
0.074
DANN
Benign
0.59
DEOGEN2
Benign
0.066
T
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.053
N
LIST_S2
Benign
0.57
T
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.0052
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.61
N
MutationTaster
Benign
0.97
N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.23
N
REVEL
Benign
0.21
Sift
Benign
0.39
T
Sift4G
Benign
0.37
T
Polyphen
0.0020
B
Vest4
0.098
MutPred
0.55
Loss of helix (P = 0.1299);
MVP
0.69
MPC
0.018
ClinPred
0.0034
T
GERP RS
-6.6
Varity_R
0.095
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138675420; hg19: chr16-83948656; COSMIC: COSV99299332; API